Merck halts testing of combination drug for lung cancer treatment
Merck said on Thursday it was halting a trial of a combination immunotherapy in patients with a type of lung cancer after an interim analysis showed the drug was unlikely to succeed.
ПОПУЛЯРНЫЕ ПОСТЫ
Poland prepares for peaking floods
Сентябрь 20, 2024
Italy evacuates thousands as Boris hits the north
Сентябрь 20, 2024
China and the US race to tame nuclear fusion for clean energy
Сентябрь 20, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ